MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies.
MFX has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in December 2022.
MFX's investors include Future Planet Capital, Esco Lifesciences, Longwall Venture, Cambridge Angels group, UK Innovation & Science Seed Fund.
MFX is headquartered in Stevenage, United Kingdom.
MFX is a platform designed to accelerate the development and manufacturing of cell and gene therapies.
MFX is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MFX — Funding & Investors." VCBacked, December 8, 2022, https://www.vcbacked.co/company/mfx. Accessed August 14, 2026.
VCBacked. (2022). MFX — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mfx
{{cite web |title=MFX — Funding & Investors |url=https://www.vcbacked.co/company/mfx |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated